Multi4 Medical Received CE Mark - Moves Bladder Cancer Treatment from Operating Room to Outpatient Setting
On 05 May 2026, the CE mark enabled the Multi4 System to be commercialized across Europe and represented a major advancement in urologic cancer care. The system introduced the world’s first all-in-one instrument, enabling urologists to perform the complete treatment endoscopically in awake patients. Procedures that traditionally required scheduled surgery and general anesthesia were completed within minutes during routine office visits.
The Multi4 instrument integrated several functions into a single platform. It delivered local anesthesia directly to the t...
